The price of Compass Therapeutics Inc (NASDAQ: CMPX) closed at $1.76 in the last session, down -7.37% from day before closing price of $1.90. In other words, the price has decreased by -$0.1400 from its previous closing price. On the day, 3027959 shares were traded.
Ratios:
We take a closer look at CMPX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 18.26 and its Current Ratio is at 18.26. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on January 31, 2023, initiated with a Buy rating and assigned the stock a target price of $8.
On January 27, 2023, Stifel started tracking the stock assigning a Buy rating and target price of $9.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 10 when Schuetz Thomas J. bought 10,000 shares for $3.37 per share. The transaction valued at 33,700 led to the insider holds 6,021,873 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMPX now has a Market Capitalization of 226.93M and an Enterprise Value of 65.27M.
Stock Price History:
Over the past 52 weeks, CMPX has reached a high of $3.98, while it has fallen to a 52-week low of $1.15. The 50-Day Moving Average of the stock is 1.5655, while the 200-Day Moving Average is calculated to be 2.1896.
Shares Statistics:
According to the various share statistics, CMPX traded on average about 518.79K shares per day over the past 3-months and 280.43k shares per day over the past 10 days. A total of 126.30M shares are outstanding, with a floating share count of 76.11M. Insiders hold about 40.30% of the company’s shares, while institutions hold 44.12% stake in the company. Shares short for CMPX as of Jan 31, 2024 were 2.18M with a Short Ratio of 4.21, compared to 2.27M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.71% and a Short% of Float of 2.39%.
Earnings Estimates
The company has 7 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.09 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.11, while EPS last year was -$0.1. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.07 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.31 and -$0.4 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.43, with 7 analysts recommending between -$0.31 and -$0.53.
